Endosomal Cleavable Linkers for Intracellular Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for linkers that can undergo cleavage, specifically endosomal cleavage or protease cleavage, to effectively activate molecules in intracellular compartments like endo-lysosomal compartments, as existing technologies struggle with efficient activation of hydrophobic conjugates and other agents within these environments.
Innovation Solution
Development of cleavable linkers that are designed to be cleaved significantly faster within intracellular conditions compared to extracellular conditions, such as blood or serum, allowing for the activation of molecules like prodrugs and nucleic acid-based effector molecules in endo-lysosomal compartments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional linkers are used to deliver molecules to intracellular compartments, then the molecules can be delivered to target cells, but the activation of prodrugs and agents within endo-lysosomal compartments is inefficient
Solution Approach 1:
The patent modifies the chemical parameters of the linker by incorporating endosomal cleavable moieties with specific pH-sensitive bonds (such as acetal, ketal, or orthoester linkages) that change their stability based on the pH environment. These linkers remain stable at physiological pH (7.4) in blood circulation but undergo rapid cleavage at the acidic pH (4.5-6.0) of endosomal compartments, thereby resolving the contradiction between delivery efficacy and activation efficiency
Solution Approach 2:
The linker design incorporates dynamic chemical bonds that transition from stable to labile states in response to environmental changes. The endosomal cleavable linker dynamically adjusts its bond stability based on pH conditions, remaining intact during circulation and automatically activating upon entering acidic endosomal compartments, thus improving both delivery and activation efficiency
2Reliability
If linkers are designed to be cleaved rapidly in intracellular conditions, then activation efficiency improves, but premature cleavage in blood or serum may occur
Solution Approach 1:
The patent exploits pH as a discriminating parameter to achieve selective cleavage. The endosomal cleavable linker contains chemical bonds with pKa values tuned to remain stable at physiological pH (preventing premature cleavage in blood) while becoming highly labile at acidic pH (enabling rapid cleavage in endosomes). This parameter-based differentiation resolves the contradiction between cleavage selectivity and premature cleavage risks
Solution Approach 2:
The acidic pH environment of endosomal compartments acts as an intermediary trigger that activates the cleavage process. The pH differential between blood and endosomes serves as a natural switch, ensuring that cleavage occurs only after the conjugate has been internalized into the target cell, thereby preventing premature activation in circulation while enabling efficient activation intracellularly
3Reliability
If conventional linkers are used, then structural simplicity is maintained, but the ability to undergo endosomal cleavage is insufficient
Solution Approach 1:
The patent creates composite linker structures by combining stable connecting units with endosomal cleavable moieties. The linker comprises a hybrid architecture where robust bonds provide structural integrity during circulation, while embedded pH-sensitive segments (such as acetal or orthoester linkages) provide the cleavage functionality. This composite design achieves endosomal cleavage capability without excessive structural complexity
Solution Approach 2:
The linker is segmented into distinct functional modules: a stable connecting segment that maintains structural integrity and an endosomal cleavable segment that provides pH-responsive activation. This segmentation allows each portion to be optimized independently—the stable segment for durability and the cleavable segment for pH sensitivity—achieving reliable endosomal cleavage with manageable overall complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cleavable linkers enable efficient activation of molecules within target cells, enhancing the delivery and efficacy of prodrugs and nucleic acid-based therapies by facilitating their activation in endo-lysosomal compartments, thereby improving pharmacokinetic profiles and gene expression modulation.
Implementation Method 1
cleavable linkers that are designed to be cleaved significantly faster within intracellular conditions compared to extracellular conditions, such as blood or serum, allowing for the activation of molecules like prodrugs and nucleic acid-based effector molecules in endo-lysosomal compartments
Data Source
AI summary
The present disclosure relates generally to cleavable linkers and uses thereof.